AU2003303335A1 - Reduction of reactive oxygen species in chronic wound management - Google Patents

Reduction of reactive oxygen species in chronic wound management Download PDF

Info

Publication number
AU2003303335A1
AU2003303335A1 AU2003303335A AU2003303335A AU2003303335A1 AU 2003303335 A1 AU2003303335 A1 AU 2003303335A1 AU 2003303335 A AU2003303335 A AU 2003303335A AU 2003303335 A AU2003303335 A AU 2003303335A AU 2003303335 A1 AU2003303335 A1 AU 2003303335A1
Authority
AU
Australia
Prior art keywords
solution
ions
wound
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303335A
Other languages
English (en)
Inventor
Hans Hoekstra
Stephen H. Monroe
A. J. J. Van Den Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of AU2003303335A1 publication Critical patent/AU2003303335A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AU2003303335A 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management Abandoned AU2003303335A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
US60/436,197 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (1)

Publication Number Publication Date
AU2003303335A1 true AU2003303335A1 (en) 2004-07-22

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303335A Abandoned AU2003303335A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Country Status (6)

Country Link
EP (1) EP1575359A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006511585A (cg-RX-API-DMAC7.html)
CN (1) CN1744819A (cg-RX-API-DMAC7.html)
AU (1) AU2003303335A1 (cg-RX-API-DMAC7.html)
CA (1) CA2511440A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004057965A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009251711B2 (en) * 2008-04-01 2014-07-17 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
DK0668769T3 (da) * 1992-11-06 2000-10-02 Greystone Medical Group Inc Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
NZ533252A (en) * 2001-11-29 2006-03-31 Greystone Medical Group Inc Treatment of wounds and compositions employed

Also Published As

Publication number Publication date
EP1575359A4 (en) 2009-08-05
JP2006511585A (ja) 2006-04-06
CN1744819A (zh) 2006-03-08
EP1575359A1 (en) 2005-09-21
CA2511440A1 (en) 2004-07-15
WO2004057965A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
US20080220091A1 (en) Reduction of reactive oxygen species in chronic wound management
Rotruck et al. Prevention of oxidative damage to rat erythrocytes by dietary selenium
Root et al. The microbicidal mechanisms of human neutrophils and eosinophils
Ferrari et al. Occurrence of oxidative stress during myocardial reperfusion
Kulkarni et al. Studies on biochemical changes with special reference to oxidant and antioxidants in malaria patients
Siegenthaler Aging of the photosynthetic apparatus zIV. Similarity between the effects of aging and unsaturated fatty acids on isolated spinach chloroplasts as expressed by volume changes
KONUKOGLU et al. Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin
Varma et al. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo
Abubakar et al. Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E
Rosado et al. Effects of reactive oxygen species on actin filament polymerisation and amylase secretion in mouse pancreatic acinar cells
Mitchell et al. Copper deficiency depresses rat aortae superoxide dismutase activity and prostacyclin synthesis
Gay et al. Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs
Kim et al. Effect of select antioxidants on malondialdehyde modification of proteins
WO2004057965A1 (en) Reduction of reactive oxygen species in chronic wound management
González et al. Diferulate and lignin formation is related tobiochemical differences of wall-bound peroxidases
Gamaley et al. Activation of murine macrophages by hydrogen peroxide
Abu-Gharbieh et al. Alleviation of Antioxidant Defense System by Ozonized Olive Oil in DNBS‐Induced Colitis in Rats
Khatami et al. Ascorbate regeneration in bovine ocular tissues by NADH-dependent semidehydroascorbate reductase
Garcı́a-González et al. Anti-inflammatory activity of Debaryomyces hansenii Cu, Zn-SOD
Van der Zee et al. The influence of ozone on human red blood cells. Comparison with other mechanisms of oxidative stress
US5578300A (en) Treatment of allergic contact dermatitis
Bozhkov et al. “Mix-Factor” is involved in the regulation of the organism's redox systems in the late stages of ontogenesis and affects the lifespan of animals
Costantino et al. Inhibitory activity of flavonols towards the xanthine oxidase enzyme
Okabe et al. Free radical damage to sarcoplasmic reticulum of masseter muscle by arachidonic acid and prostaglandin G2
Kazimierczak et al. The mechanism of histamine release induced by the ionophore X537A from isolated rat mast cells: 1. Significance of Monovalent Cations, Calcium, Metabolic Energy and Temperature

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted